Comparative Effectiveness of Interventional Therapy versus Exercise Rehabilitation in Stable Angina Patients with

Yucheng Wu1, Jie Qiu1, Xiang Sha1

  • 1Department of Cardiology, Taizhou School of Clinical Medicine, Nanjing Medical University, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, Jiangsu Province, 225300, People's Republic of China.

PubMed

Insights

For stable angina with severe stenosis, percutaneous coronary intervention (PCI) did not reduce cardiovascular events more than exercise-based cardiac rehabilitation (CR). However, CR significantly improved cardiovascular fitness and quality of life.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Rehabilitation Medicine

Background:

  • Stable angina management includes pharmacotherapy, revascularization, and cardiac rehabilitation (CR).
  • Optimal treatment for severe coronary artery stenosis in stable angina remains unclear.
  • This study compared interventional therapy versus exercise rehabilitation.

Purpose of the Study:

  • To compare the efficacy of percutaneous coronary intervention (PCI) plus optimal medical therapy (OMT) versus OMT plus CR in stable angina patients with severe coronary stenosis.
  • To evaluate cardiovascular composite endpoint events, cardiopulmonary fitness, and quality of life.

Main Methods:

  • Fifty patients received OMT plus PCI (stent implantation).
  • Fifty patients received OMT plus CR with exercise rehabilitation guidance for one year.
  • Outcomes assessed included cardiovascular events, peak VO2, peak load, anaerobic threshold (AT), and quality of life scores.

Main Results:

  • No significant difference in cardiovascular composite endpoint events between OMT+PCI and OMT+CR groups (20.0% vs 14.6%).
  • Cardiopulmonary fitness (peak VO2, peak load, AT) was significantly higher in the OMT+CR group.
  • Both groups improved quality of life, with greater improvements in more scales for the OMT+CR group.

Conclusions:

  • Interventional therapy (PCI) did not confer a greater reduction in cardiovascular events compared to exercise-based CR.
  • Exercise-based CR demonstrated superior improvements in cardiovascular fitness and quality of life.
  • CR is a viable and potentially more beneficial alternative for managing stable angina with severe coronary stenosis.
Abstract

Related Concept Videos

Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
464
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
750
Exercise Stress Test01:26

Exercise Stress Test

Introduction
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
184
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
404
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
547
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
322